|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C12N 15/13 | |||
| C12N 5/20 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 14/705 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3309177 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17759275.5 |
| Europos patento paraiškos padavimo data | 2017-03-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/075484 |
| Data | 2017-03-02 |
| (87) | Numeris | WO 2017/148424 |
| Data | 2017-09-08 |
| (30) | Numeris | Data | Šalis |
| 201610122117 | 2016-03-04 | CN |
| (72) |
LI, Baiyong, CN
XUE, Tongtong, CN
XIA, Yu, CN
WANG, Zhongmin Maxwell, CN
XIAO, Liang, CN
WANG, Lichun, CN
WANG, Jingyi, CN
|
| (73) |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.,
No.666, Xinhua Avenue (section 2) Hai Xia Industrial Park Wenjiang District, Chengdu, Sichuan 611138,
CN
|
| (54) | PDL-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF |
| PDL-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF |